{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:47:32Z","timestamp":1780764452668,"version":"3.54.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"DOI":"10.2146\/ajhp110603","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T17:00:05Z","timestamp":1345136405000},"page":"1500-1508","source":"Crossref","is-referenced-by-count":114,"title":["Clinical and economic outcomes of a prospective antimicrobial stewardship program"],"prefix":"10.1093","volume":"69","author":[{"given":"Michael A.","family":"Nowak","sequence":"first","affiliation":[{"name":"College of Pharmacy, California Northstate University, Rancho Cordova; at the time of writing he was Pharmacy Practice Resident, Sanford Medical Center, Fargo, ND."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Nelson","sequence":"additional","affiliation":[{"name":"ViroPharma Incorporated, Fargo, ND; at the time of writing he was Pharmacy Clinical Manager, Sanford Medical Center."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Breidenbach","sequence":"additional","affiliation":[{"name":"Sanford Medical Center, Fargo, ND."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Sanford Research and University of South Dakota, Sioux Falls."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Carson","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Pulmonary Medicine, and Director of Research, Sanford Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019041607100501400_b1-0691500","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/003335490712200205","article-title":"Estimating health care-associated infections and deaths in U.S. hospitals, 2002","volume":"122","author":"Klevens","year":"2007","journal-title":"Public Health Rep"},{"issue":"suppl 1","key":"2019041607100501400_b2-0691500","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/591060","article-title":"A compendium of strategies to prevent health care-associated infections in acute care hospitals","volume":"29","author":"Yokoe","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019041607100501400_b3-0691500","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b4-0691500","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","article-title":"Overview of nosocomial infections caused by gram-negative bacilli","volume":"41","author":"Gaynes","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b5-0691500","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/499367","article-title":"Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992\u20132003","volume":"42","author":"Klevens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b6-0691500","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ajic.2004.02.008","article-title":"Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital","volume":"32","author":"Wilson","year":"2004","journal-title":"Am J Infect Control"},{"key":"2019041607100501400_b7-0691500","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/502488","article-title":"Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study","volume":"26","author":"Qavi","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019041607100501400_b8-0691500","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/502196","article-title":"Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs","volume":"24","author":"Song","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019041607100501400_b9-0691500","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00207-10","article-title":"Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes","volume":"54","author":"Tam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"2019041607100501400_b10-0691500","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b11-0691500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"2019041607100501400_b12-0691500","first-page":"S397","article-title":"Combating antimicrobial resistance: policy recommendations to save lives","volume":"52","author":"Spellberg","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b13-0691500","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/652237","article-title":"The 10 \u00d7 20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b14-0691500","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same?","volume":"163","author":"Coates","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"suppl 1","key":"2019041607100501400_b15-0691500","doi-asserted-by":"crossref","first-page":"i59","DOI":"10.1093\/jac\/dkm160","article-title":"The zeitgeist of resistance","volume":"60","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2019041607100501400_b16-0691500","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.163.8.972","article-title":"Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity","volume":"163","author":"Hecker","year":"2003","journal-title":"Arch Intern Med"},{"key":"2019041607100501400_b17-0691500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2334-11-187","article-title":"Unnecessary use of fluoroquinolone antibiotics in hospitalized patients","volume":"11","author":"Werner","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2019041607100501400_b18-0691500","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/513766","article-title":"Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals","volume":"25","author":"Shlaes","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b19-0691500","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/infdis\/157.5.869","article-title":"Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America","volume":"157","author":"Marr","year":"1988","journal-title":"J Infect Dis"},{"key":"2019041607100501400_b20-0691500","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b21-0691500","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.163.5.601","article-title":"Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use","volume":"163","author":"Lautenbach","year":"2003","journal-title":"Arch Intern Med"},{"key":"2019041607100501400_b22-0691500","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/501754","article-title":"Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA\/IDSA position paper recommendations. Society for Healthcare Epidemiology of America\/Infectious Diseases Society of America","volume":"21","author":"Lawton","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019041607100501400_b23-0691500","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.279.11.875","article-title":"Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis","volume":"279","author":"Nyquist","year":"1998","journal-title":"JAMA"},{"key":"2019041607100501400_b24-0691500","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.idc.2009.06.005","article-title":"Controlling antimicrobial resistance in the hospital","volume":"23","author":"Anderson","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"2019041607100501400_b25-0691500","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2146\/sp100001","article-title":"ASHP statement on the pharmacist\u2019s role in antimicrobial stewardship and infection prevention and control","volume":"67","author":"American Society of Health-System Pharmacists","year":"2010","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041607100501400_b26-0691500","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/592067","article-title":"The value of infectious diseases specialists: non-patient care activities","volume":"47","author":"McQuillen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b27-0691500","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jac\/dkr137","article-title":"Impact of antimicrobial stewardship in critical care: a systematic review","volume":"66","author":"Kaki","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2019041607100501400_b28-0691500","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1592\/phco.24.9.896.36101","article-title":"Antimicrobial stewardship programs as a means to optimize antimicrobial use. Insights from the Society of Infectious Diseases Pharmacists","volume":"24","author":"Owens","year":"2004","journal-title":"Pharmacotherapy"},{"key":"2019041607100501400_b29-0691500","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/14787210.6.2.209","article-title":"Antimicrobial stewardship programs: interventions and associated outcomes","volume":"6","author":"Patel","year":"2008","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"2019041607100501400_b30-0691500","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1592\/phco.29.6.736","article-title":"An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse","volume":"29","author":"Wong-Beringer","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2019041607100501400_b31-0691500","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1086\/321880","article-title":"Impact of a hospital-based antimicrobial management program on clinical and economic outcomes","volume":"33","author":"Gross","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b32-0691500","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1086\/375818","article-title":"A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance","volume":"37","author":"Bantar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b33-0691500","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/ajhp\/57.3.268","article-title":"Outcomes of an antimicrobial control program in a teaching hospital","volume":"57","author":"Gentry","year":"2000","journal-title":"Am J Health-Syst Pharm"},{"key":"2019041607100501400_b34-0691500","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/502278","article-title":"Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years","volume":"24","author":"Carling","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2019041607100501400_b35-0691500","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0195-6701(03)00115-4","article-title":"Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital","volume":"54","author":"Khan","year":"2003","journal-title":"J Hosp Infect"},{"key":"2019041607100501400_b36-0691500","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/500325","article-title":"Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand","volume":"42","author":"Apisarnthanarak","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019041607100501400_b37-0691500","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/338639","article-title":"Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites","volume":"34","author":"Rahal","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"2019041607100501400_b38-0691500","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2005.01238.x","article-title":"Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance","volume":"11","author":"Peterson","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"2019041607100501400_b39-0691500","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jama.280.14.1270","article-title":"Antibiotic resistance\u2014squeezing the balloon?","volume":"280","author":"Burke","year":"1998","journal-title":"JAMA"},{"key":"2019041607100501400_b40-0691500","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society, Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2019041607100501400_b41-0691500","unstructured":"Collaborating Centre for Drug Statistics Methodology, World Health Organization. Guidelines for ATC classification and DDD assignment. www.whocc.no\/atc_ddd_publications\/guidelines (accessed 2012 Apr 24)."},{"key":"2019041607100501400_b42-0691500","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00134-003-2088-1","article-title":"Clinical cure and survival in gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin","volume":"30","author":"Kollef","year":"2004","journal-title":"Intensive Care Med"},{"key":"2019041607100501400_b43-0691500","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1378\/chest.08-0011","article-title":"Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus","volume":"134","author":"Wunderink","year":"2008","journal-title":"Chest"},{"key":"2019041607100501400_b44-0691500","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"issue":"suppl 2","key":"2019041607100501400_b45-0691500","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1086\/519258","article-title":"Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hyper-virulent NAP1\/027 strain","volume":"45","author":"Valiquette","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"suppl 4","key":"2019041607100501400_b46-0691500","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/382690","article-title":"\u201cCollateral damage\u201d from cephalosporin or quinolone antibiotic therapy","volume":"38","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"2019041607100501400_b47-0691500","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"RR-12","key":"2019041607100501400_b48-0691500","first-page":"1","article-title":"Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)","volume":"44","author":"Recommendations for preventing the spread of vancomycin resistance","year":"1995","journal-title":"MMWR Recomm Rep"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/17\/1500\/28455312\/ajhp1500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:20:34Z","timestamp":1555413634000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/17\/1500\/5111997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":48,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110603","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,9,1]]},"published":{"date-parts":[[2012,9,1]]}}}